Screener
ANI Pharmaceuticals ANIP CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net Cash and Cash Equivalents Provided by Operating Activities | 115,044 | 110,803 |
| Cash Flows From Investing Activities | ||
| Acquisition of product rights, intangible assets, and other related assets | (5,250) | (20,267) |
| Acquisition of property and equipment, net | (9,128) | (6,488) |
| Net Cash and Cash Equivalents Used in Investing Activities | (14,378) | (26,755) |
| Cash Flows From Financing Activities | ||
| Principal payments on borrowings | (8,125) | (4,062) |
| Series A convertible preferred stock dividends paid | — | (813) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's capex?
- ANI Pharmaceuticals (ANIP) reported capex of $3.05M in Q2 2026.
- How has ANI Pharmaceuticals's capex changed year-over-year?
- ANI Pharmaceuticals's capex decreased by 23.9% year-over-year, from $4.01M to $3.05M.
- What is the long-term trend for ANI Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's capex has grown at a 52.5% compound annual growth rate (CAGR), from $2.56M to $13.84M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about ANI Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude